As a result of difficulties in penetrating the European market because of growing consumer awareness and rejection, biotech corporations and the governments that back them have turned to the developing world, particularly Africa. […]
|
||||||
|
As a result of difficulties in penetrating the European market because of growing consumer awareness and rejection, biotech corporations and the governments that back them have turned to the developing world, particularly Africa. […] Argentina’s disastrous experience with GE crops should be an object lesson to developing countries which cling to the illusion that this technology will foster genuine development, says an activist. […] The First Meeting of the Parties to the Cartagena Protocol on Biosafety is tasked with building an international biosafety system, including a liability and redress regime. Lim Li Ching highlights evidence of hazards that can throw light on the way forwar […] Edible vaccines are being touted by the agbiotech industry as an example of the benefits genetic engineering can bring to the South. But we will all likely be a lot better off without it. […] Is so-called ‘therapeutic’ human cloning really necessary? […] Despite warnings from scientists of the risk of new viruses crossing from animal organs to human subjects and thereby infecting the population at large, xenotransplantation is a multi-billion-dollar venture. […] The following article considers whether there is any justification for the optimistic outlook for biotechnology and whether it would be prudent for developing countries to devote their limited financial resources to this technology. […] The First Meeting of the Parties to the Cartagena Protocol on Biosafety is tasked with building an international biosafety system. Lim Li Ching highlights evidence of hazards in the way forward. […] No persuasive reason exist for cloning save for genetic determinists who believe an organism is nothing more than the sum total of its genetic make-up and that it is their right to exploit cloned human embryos for spare body parts. […] The relationship between the Cartagena Protocol on Biosafety and the WTO agreements has yet to be settled. The following article examines how the WTO agreements impact on biosafety and the Cartagena Protocol. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||